Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 114,533,051
- Total 13F value
- $1,628,519,417
- Share change
- +7,918,046
- Put/Call ratio
- 55%
- SEC-reported price per share
- $14.30
- Number of holders
- 120
- Value change
- +$98,165,187
- Number of buys
- 66
- Number of sells
- 55
- Shares outstanding
- 305,667,944
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
120
Top holders
10
ABCL full security history
Ownership snapshot
Full 13F holder table
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
DCVC Bio, L.P.
Disclosed value leader
Capital World Investors
Comparable rows
0/15
Latest evidence
30 Sep 2021
3/4/5
13F
Highest disclosed value: $397,221,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Capital World Investors has the largest disclosed position value at $397.22M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital World Investors's linked filing trail.
Disclosed position value
Top 5
DCVC Bio, L.P.
$199.5K
Capital World Investors
$397.22M
Allianz Asset Management GmbH
$237.65M
BAKER BROS. ADVISORS LP
$209.42M
SB Management Ltd
$196.74M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DCVC Bio, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$199,508
73,892 shares
|
— | 18 Jun 2021 |
| Capital World Investors |
13F
Company
|
—
denominator unverified
|
$397,221,000
19,821,407 shares
|
— | 30 Sep 2021 |
| Allianz Asset Management GmbH |
13F
Company
|
—
denominator unverified
|
$237,650,000
11,858,796 shares
|
— | 30 Sep 2021 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$209,422,000
10,450,180 shares
|
— | 30 Sep 2021 |
| SB Management Ltd |
13F
Company
|
—
denominator unverified
|
$196,736,000
9,817,190 shares
|
— | 30 Sep 2021 |
| Capital International Investors |
13F
Company
|
—
denominator unverified
|
$142,482,000
7,109,889 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
120
Shares
114,533,051
Rows available
120
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
115
Q4 2021 holders
120
Holder diff
5
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|